StockStory.org on MSN
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an ...
DexCom receives FDA clearance for DexCom Smart Basal titration software module, which optimizes basal insulin dose in type 2 ...
These healthcare stocks have long-term and profitable growth runways.
Weeks after launching its first open call for diabetes advocates, Dexcom is spotlighting the resulting group of 16 people in ...
In honor of National Diabetes Awareness Month, DAV (Disabled American Veterans) announced today a new strategic partnership with Dexcom, the global leader in glucose biosensing. As part of the ...
The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that securities class action lawsuits have been ...
Since last year, DexCom ( DXCM +5.54%) has faced a series of issues that have sunk its stock price. The medical device ...
The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that securities class action lawsuits have been ...
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is ...
Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...
StockStory.org on MSN
3 Reasons We’re Fans of DexCom (DXCM)
Why Is DexCom a Good Business? Founded in 1999 and receiving its first FDA approval in 2006, DexCom (NASDAQ:DXCM) develops ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results